These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29122712)

  • 1. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosystems as modulators of intestinal dapsone and clofazimine delivery.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Biomed Pharmacother; 2018 Jul; 103():1392-1396. PubMed ID: 29864923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles.
    Chaves LL; Lima S; Vieira ACC; Ferreira D; Sarmento B; Reis S
    J R Soc Interface; 2018 Feb; 15(139):. PubMed ID: 29436513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.
    Valetti S; Xia X; Costa-Gouveia J; Brodin P; Bernet-Camard MF; Andersson M; Feiler A
    Nanomedicine (Lond); 2017 Apr; 12(8):831-844. PubMed ID: 28338408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
    Bairwa K; Jachak SM
    J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
    Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
    Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
    Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    Siu FY; Ye S; Lin H; Li S
    Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taguchi design for optimization and development of antibacterial drug-loaded PLGA nanoparticles.
    Sonam ; Chaudhary H; Kumar V
    Int J Biol Macromol; 2014 Mar; 64():99-105. PubMed ID: 24315945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
    J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of PLGA nanoparticles with mucoadhesive guar-gum films for buccal delivery of antihypertensive peptide.
    Castro PM; Baptista P; Madureira AR; Sarmento B; Pintado ME
    Int J Pharm; 2018 Aug; 547(1-2):593-601. PubMed ID: 29800740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.